Thrombosis prophylaxis after treatment during pregnancy

被引：19

作者：

Daskalakis, G ^{[1
]}

Antsaklis, A ^{[1
]}

Papageorgiou, I ^{[1
]}

Michalas, S ^{[1
]}

机构：

[1] UNIV ATHENS,SCH MED,ALEXANDRA MATERN HOSP,DEPT OBSTET & GYNECOL 1,GR-11527 ATHENS,GREECE

来源：

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1997年 / 74卷 / 02期

关键词：

pregnancy; thrombosis; heparin; low molecular weight heparin;

D O I：

10.1016/S0301-2115(97)00110-3

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Deep vein thrombosis (DVT) is not a rare occurrence during pregnancy and puerperium due to changes in the coagulation mechanism. Eighteen cases with DVT during pregnancy are presented here. All of them received subcutaneous heparin for two weeks at a dose adjusted so as to prolong the activated partial thromboplastin time, or plasma recalcification time, to twice that of normal controls. Treatment continued with low molecular weight heparin (LMWH), once daily subcutaneously, for the duration of pregnancy and for one month postpartum. All women went into labor uneventfully, except for one who had a missed abortion during the 10th week. No side-effects were observed. LMWH has some advantages compared with standard heparin, which make it the treatment of choice for the prevention of thromboembolic events in pregnant women. (C) 1997 Elsevier Science Ireland Ltd.

引用

页码：165 / 167

页数：3

共 20 条

[1] RECURRENCE OF VENOUS THROMBOEMBOLIC DISEASE AND USE OF ORAL-CONTRACEPTIVES [J].

BADARACC.MA ;

VESSEY, MP .

BRITISH MEDICAL JOURNAL, 1974, 1 (5901) :215-217

[2]

BERGQVIST D, 1987, THROMB HAEMOST S, V1, pA1393

[3] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].

BERTINA, RM ;

KOELEMAN, BPC ;

KOSTER, T ;

ROSENDAAL, FR ;

DIRVEN, RJ ;

DERONDE, H ;

VANDERVELDEN, PA ;

REITSMA, PH .

NATURE, 1994, 369 (6475) :64-67

[4] LOW-MOLECULAR-WEIGHT HEPARIN (KABI-2165, FRAGMIN) - PHARMACOKINETICS AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMAN VOLUNTEERS [J].

BRATT, G ;

TORNEBOHM, E ;

WIDLUND, L ;

LOCKNER, D .

THROMBOSIS RESEARCH, 1986, 42 (05) :613-620

[5]

CONARD J, 1990, THROMB HAEMOSTASIS, V63, P319

[6] FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].

DAHLBACK, B ;

CARLSSON, M ;

SVENSSON, PJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008

[7]

Fejgin M D, 1994, Obstet Gynecol Surv, V49, P424, DOI 10.1097/00006254-199406000-00025

[8] PLACENTAL TRANSPORT OF HEPARIN [J].

FLESSA, HC ;

KAPSTROM, AB ;

GLUECK, HI ;

WILL, JJ .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1965, 93 (04) :570-&

[9] USE OF LOW-MOLECULAR-WEIGHT HEPARIN FOR PROPHYLAXIS AND TREATMENT OF THROMBOEMBOLISM IN PREGNANCY [J].

GILLIS, S ;

SHUSHAN, A ;

ELDOR, A .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 39 (04) :297-301

[10]

GINSBERG JS, 1989, CHEST S, V95, P156

← 1 2 →